Neurogenic bladder in Lambert–Eaton myasthenic syndrome and its response to 3,4-diaminopyridine
✍ Scribed by Katsuya Satoh; Masakatsu Motomura; Hiroshi Suzu; Yoko Nakao; Takeshi Fujimoto; Taku Fukuda; Shunya Nakane; Tatsufumi Nakamura; Katsumi Eguchi
- Book ID
- 119465272
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 193 KB
- Volume
- 183
- Category
- Article
- ISSN
- 0022-510X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The high incidence of elevated immunoglobulin (Ig)G anti-GQ1b antibody in sera from patients with acute phase Miller-Fisher syndrome (MFS) was first reported by Chiba et al. 1 and later confirmed by two other groups. 3,4 Chiba et al. 2 pointed out that anti-GQ1b IgG antibody is associated specifical
A patient with LEMS unrelated to cancer was studied by ## CASE OF THE MONTH stimulated single-fiber electromyography (SFEMG) before and 3 months after the onset of therapy with 3,4-diaminopyridine. All end-plates showed Section Editors a progressive reduction in blockings and jitter with the incr